KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Other Non-Current Liabilities: 2010-2024

Historic Other Non-Current Liabilities for Emergent BioSolutions (EBS) over the last 15 years, with Dec 2024 value amounting to $39.1 million.

  • Emergent BioSolutions' Other Non-Current Liabilities rose 18.99% to $42.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.6 million, marking a year-over-year increase of 18.99%. This contributed to the annual value of $39.1 million for FY2024, which is 35.29% up from last year.
  • Latest data reveals that Emergent BioSolutions reported Other Non-Current Liabilities of $39.1 million as of FY2024, which was up 35.29% from $28.9 million recorded in FY2023.
  • Emergent BioSolutions' 5-year Other Non-Current Liabilities high stood at $69.5 million for FY2021, and its period low was $28.9 million during FY2023.
  • Its 3-year average for Other Non-Current Liabilities is $36.5 million, with a median of $39.1 million in 2024.
  • As far as peak fluctuations go, Emergent BioSolutions' Other Non-Current Liabilities soared by 39.51% in 2020, and later plummeted by 40.29% in 2022.
  • Over the past 5 years, Emergent BioSolutions' Other Non-Current Liabilities (Yearly) stood at $67.8 million in 2020, then climbed by 2.51% to $69.5 million in 2021, then crashed by 40.29% to $41.5 million in 2022, then slumped by 30.36% to $28.9 million in 2023, then skyrocketed by 35.29% to $39.1 million in 2024.